To determine whether Hace1 KO mice develop any clinical symptoms of SPPRS patients, we first analyzed structural and cellular features of mutant mouse brains using 15.2 T MRI and/or histologic staining at different developmental stages. The gene discussed is HACE1; the disease is spastic paraplegia-severe developmental delay-epilepsy syndrome.